Skip to main content

Animations

MJFF Publications

3961 - 3970 of 6456 Results
Title
Year
  • Year
  • 2020
  • 2023
  • 2023
  • 2021
  • 2026
  • 2018
  • 2023
  • 2021
  • 2025
  • 2022
  • Summary Details
    OPEN
    Title: The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBAC
    Journal Name: Science Signaling
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scisignal.aav1256
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad072
    Citation Count: 122
  • Summary Details
    OPEN
    Title: Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00555-4
    Citation Count: 23
  • Summary Details
    OPEN
    Title: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100448
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-018-1449-2
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-42813-8
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409
    Citation Count: 35
  • Summary Details
    OPEN
    Title: α-Synuclein seed amplification assay positivity beyond synucleinopathies
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105925
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Transmembrane protein ATG-9 links presynaptic autophagy with the synaptic vesicle cycle
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2049151
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.